Jan 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including GE Healthcare, Summit Materials and Tapestry, on Wednesday.
HIGHLIGHTS
* GE Healthcare GEHC.O: Jefferies raises to buy from hold |
* Philip Morris International Inc. PM.N: Barclays cuts target price to $145 from $155 |
* Regeneron Pharmaceuticals Inc REGN.O: Truist Securities cuts PT to $1004 from $1126 |
* Summit Materials Inc SUM.N: Stephens cuts to equal weight from overweight |
* Tapestry Inc TPR.N: Barclays raises to overweight from equal weight |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Abbvie ABBV.N: Truist Securities cuts target price to $211 from $215 |
* Affirm Holdings Inc AFRM.O: RBC raises target price to $67 from $52 |
* Amgen Inc AMGN.O: Truist Securities cuts target price to $298 from $333 |
* Biogen BIIB.O: Truist Securities cuts target price to $220 from $302 |
* Bristol-Myers Squibb Co BMY.N: Truist Securities raises PT to $65 from $62 |
* Constellation Energy Corp CEG.O: JP Morgan raises target price to $348 from $342 |
* Enact Holdings Inc ACT.O: KBW cuts target price to $41 from $43 |
* Fidelity National Financial Inc FNF.N: KBW cuts target price to $63 from $64 |
* First American Financial Corp FAF.N: KBW cuts target price to $74 from $80 |
* GE Healthcare GEHC.O: Jefferies raises target price to $103 from $95 |
* GE Healthcare GEHC.O: Jefferies raises to buy from hold |
* Getty Realty Corp GTY.N: RBC cuts target price to $32 from $33 |
* Inari Medical Inc NARI.O: Jefferies cuts to hold from buy |
* Inari Medical Inc NARI.O: Jefferies raises target price to $80 from $70 |
* Levi Strauss & Co LEVI.N: Barclays initiates coverage with overweight rating; PT $24 |
* Lindsay Corp LNN.N: Stifel raises target price to $130 from $126 |
* Merck & Co Inc MRK.N: Truist Securities cuts target price to $110 from $130 |
* Merck & Co Inc MRK.N: Truist Securities cuts to hold from buy |
* Meritage Homes Corp MTH.N: KBW cuts target price to $97 from $194 |
* Mgic Investment Corp MTG.N: KBW cuts target price to $28 from $29 |
* Nektar Therapeutics NKTR.O: B. Riley initiates coverage with buy rating; PT $4 |
* Nextera Energy Partners LP NEP.N: CIBC cuts target price to $21 from $26 |
* Nike Inc NKE.N: RBC cuts target price to $70 from $80 |
* NMI Holdings Inc NMIH.O: KBW cuts target price to $43 from $44 |
* Philip Morris International Inc. PM.N: Barclays cuts target price to $145 from $155 |
* Phreesia Inc PHR.N: RBC raises to outperform from sector perform; ups PT to $32 from $24 |
* Radian Group Inc RDN.N: KBW cuts target price to $40 from $41 |
* Regeneron Pharmaceuticals Inc REGN.O: Truist Securities cuts PT to $1004 from $1126 |
* RPM International Inc RPM.N: JP Morgan cuts target price to $124 from $126 |
* Stewart Information Services Corp STC.N: KBW cuts target price to $74 from $84 |
* Summit Materials Inc SUM.N: Stephens cuts target price to $52.50 from $56 |
* Summit Materials Inc SUM.N: Stephens cuts to equal weight from overweight |
* Talen Energy Corp TLN.O: JP Morgan raises target price to $288 from $268 |
* Tapestry Inc TPR.N: Barclays raises target price to $87 from $57 |
* Tapestry Inc TPR.N: Barclays raises to overweight from equal weight |
* Vistra Corp VST.N: JP Morgan raises target price to $180 from $178 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。